FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like DexCom Appoints To Board Of Directors March 12, 2017 This Drug Could be Johnson & Johnson's Next Billion-Dollar Blockbuster January 25, 2017 ImmunoGen Stock Climbs on Positive Ovarian Cancer Data March 25, 2018
